News for Unity Biotechnology, Inc. (UBX)

Published at

Mar 7, 2025 11:00 PM

by gurufocus.com

neutral

neutral

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

SAN FRANCISCO, March 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (”UNITY”) [ UBX], a biotechnology company developing therapeutics to slow, hal

UBX 0YC0.L

Read more →
Published at

Mar 7, 2025 10:44 PM

by manilatimes.net

neutral

neutral

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

**media[560539]**

UBX 0YC0.L

Read more →
Published at

Mar 7, 2025 10:35 PM

by seekingalpha.com

negative

negative

Unity Biotechnology GAAP EPS of -$0.50 misses by $0.14 (NASDAQ:UBX)

Unity Biotechnology (UBX) Q4 results: GAAP EPS of -$0.50, missing estimates by $0.14.

UBX

Read more →
Published at

Jan 16, 2025 5:01 PM

by gurufocus.com

positive

positive

Empery Asset Management, LP Increases Stake in Sobr Safe Inc

Empery Asset Management, LP (Trades, Portfolio) recently expanded its investment portfolio by acquiring an additional 97,134 shares of Sobr Safe Inc on December

UBX SOBR ETNB 0YC0.L

Read more →
Published at

Jan 15, 2025 5:02 PM

by gurufocus.com

positive

positive

Empery Asset Management, LP Increases Stake in Greenlane Holdings Inc

On December 31, 2024, Empery Asset Management, LP (Trades, Portfolio) made a significant move by acquiring an additional 184,573 shares of Greenlane Holdings In

UBX GNLN ETNB 0YC0.L

Read more →
Published at

Jan 10, 2025 7:02 PM

by gurufocus.com

positive

positive

Empery Asset Management, LP's Strategic Acquisition in Critical Metals Corp

On December 31, 2024, Empery Asset Management, LP (Trades, Portfolio), a prominent player in the investment landscape, executed a noteworthy transaction by acqu

UBX ETNB 0YC0.L

Read more →
Published at

Jan 7, 2025 11:00 PM

by gurufocus.com

positive

positive

UNITY Biotechnology Reports Granting of New Employment Inducement Award

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (”UNITY”) [ UBX], a biotechnology company developing therapeutics

UBX 0YC0.L

Read more →
Published at

Jan 6, 2025 2:42 PM

by seekingalpha.com

neutral

neutral

Unity Biotechnology gets new chief medical officer (NASDAQ:UBX)

UNITY Biotechnology appoints Federico Grossi, M.D., Ph.D., as chief medical officer.

UBX

Read more →
Published at

Jan 6, 2025 2:00 PM

by gurufocus.com

positive

positive

UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer

SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (”UNITY”) [ UBX], a biotechnology company developing therapeutics to slow, halt

UBX 0YC0.L

Read more →
Published at

Nov 4, 2024 11:20 PM

by investing.com

neutral

neutral

UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates By Investing.com

UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates

UBX 0YC0.L

Read more →
Published at

Oct 16, 2024 7:01 PM

by gurufocus.com

positive

positive

Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals

Overview of the Recent Transaction On September 30, 2024, Empery Asset Management, LP (Trades, Portfolio), a notable investment firm, expanded its portfolio by

UBX TNXP 0YC0.L 0A4T.L

Read more →
Published at

Oct 9, 2024 7:02 PM

by gurufocus.com

positive

positive

Empery Asset Management, LP Acquires Shares in Volcon Inc

Introduction to the Transaction On September 30, 2024, Empery Asset Management, LP (Trades, Portfolio) made a notable addition to its investment portfolio by ac

UBX 0YC0.L

Read more →
Published at

Oct 9, 2024 7:02 PM

by gurufocus.com

positive

positive

Empery Asset Management's Strategic Acquisition in Elevation Oncology

Overview of the Recent Transaction On September 30, 2024, Empery Asset Management, LP (Trades, Portfolio) made a significant addition to its investment portfoli

UBX 0YC0.L

Read more →
Published at

Oct 8, 2024 7:00 PM

by globenewswire.com

mixed

mixed

VEGFR-2 Antagonists Clinical Trial Pipeline Insights Featuring 25+ Companies | DelveInsight

VEGFR2 (vascular endothelial growth factor receptor 2) antagonist is an antineoplastic agent that blocks the binding of natural VEGF ligands, which are...

OTLK 321550.KQ UBX OPT.AX OPT LLY.DE LLY.BA LLY LILY34.SA KOD EYPT CKDXF AGTC 0YC0.L 0Q1G.L OCUL INCY I1NC34.SA CLSD ADVM 214370.KQ 0J9P.L 0HA3.L

Read more →
Published at

Jan 31, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Wet-Age Related Macular Degeneration Market to Observe Stupendous Growth by 2032, Predicts DelveInsight | Key Players - AbbVie, Opthea, AffaMed Therapeutics, EyeBiotech, Novartis, Hoffmann-La Roche, K

The increasing number of diagnosed cases of wet AMD, the current therapies, and the launch of emerging therapies will drive the wet AMD market growth in...

OPT.AX OPT EYPT CKDXF UBX OTLK OCUL KOD.MX KOD CLSD ADVM 214370.KQ 0YC0.L 0HA3.L

Read more →
Published at

Jun 13, 2022 5:30 PM

by prnewswire.com

mixed

mixed

Age-related Macular Degeneration Market to Progress at a CAGR of 3.4% by 2032 | DelveInsight

/PRNewswire/ -- DelveInsight's Age-related Macular Degeneration Market Insights report includes a comprehensive understanding of current treatment practices,...

OTLK OPT.AX OPT CKDXF 4591.T UBX KOD.MX KOD 0YC0.L

Read more →
Published at

May 18, 2022 7:50 PM

by etfdailynews.com

mixed

mixed

Equities Research Analysts’ Downgrades for May 18th (APO, APPF, AZN, BYCBF, CARR, CCBG, CENX, CF, CLH, CRH)

Read Equities Research Analysts’ Downgrades for May 18th (APO, APPF, AZN, BYCBF, CARR, CCBG, CENX, CF, CLH, CRH) at ETF Daily News

WTI VTRU VLDRW VLDR VEO.DE VECO USWS UI UEIC UBX TUFN TRVI SWDBY SWDBF SUBCY SUBCO.OL SUBC.OL STSA SSRM.TO SSRM SSR.AX SSL.TO SOHOO SOHON SOHOB SOHO SOBKY SMSOF SMSEY SFBQF SCVL SBFG SAND QUMU PTXKY PTXAF PTX.DE PSTL PSALL PSA.MX PSA-PQ PSA-PP PSA PMCBD PMCB PLYM PLTR NVEE NTCT NREF-PA NREF NICXF NBY MU MIRM.MX MIRM METC LIII-UN LIII LAZR.MX LAZR KELYB KELYA JPMML JPM JAGX ISDR IRIX ILPT HAFC GMHIU FAF EXCL.JK DVN COX.PA CLH APO ACGYF 9434.T 1910.HK 0YC0.L 0VGM.L 0VGE.L 0RCQ.L 0A7R.L 0A72.L ZSV.DE VSEC TYRA TPGS STN.TO STN SRRA SIX RY PYPD NTAP MYE MVBF MUR MGTX MGTA LOKB-UN LOKB LOAK-UN KURA KB HOPE GSGI34.SA GS.MX GS.BA GS GOS.DE GAN GAINM GAINL GAIN FLNT CTBK CRK CRH CGROW CGROU CGRO CENX CCBG CARR BYCBF AZN APPF VOR

Read more →
Published at

May 17, 2022 8:02 PM

by etfdailynews.com

mixed

mixed

Equities Research Analysts’ Price Target Changes for May 17th (ABT, ADGI, ADSK, AEO, AFRM, AGIO, ALBO, ALGT, ALO, ALV)

Read Equities Research Analysts’ Price Target Changes for May 17th (ABT, ADGI, ADSK, AEO, AFRM, AGIO, ALBO, ALGT, ALO, ALV) at ETF Daily News

ZNTL WSM VERB URBN TNDM SCPH PXS PSXD.BA PSX.MX PSX.BA PSX PCYG MYPS MSGM MQ MPC MANT HOLX HHULY HHFA.DE HENOY HENOF HENKY HENK.BD HEN3.MI HEN3.DE HEN.DE HELKF HARP H GSGI34.SA GS.MX GS.BA GS GOS.DE FR FPAY FIXX EMR DG.PA CMRX CLNE CELC BYMOF BMY BMWYY BMWM5N.MX BMW3.DE BMW.MI BMW.DE BAMXF ABTCL.SN ABT.SN ABT 0KHZ.L YOU WMT WMG WFC WDAY VLO UBX UBSN.MX UBSGEE.SW UBSGE.SW UBSG34.SA UBSG.SW UBS TVTX TSHA TRVC.DE TRNO SPRO SHLS RY RKT REKR PODD PAVM PASG NEX MSCL.SN LUNG LBRDK JPMML JPMCL.SN JPMC.BA JPM JNJ JEF.MX JEF ISRG IMBI IGMS IDYA GNMSF GMABN.MX GMAB GKOS GFF GAN GALT FSR FITBP FITBO FITBI FITB FIS EVH ETR EQR DRE DJNJ3.BA DJNJ2.BA DBTX CSN.MX CSGNE.SW CSGN.SW CSGKF CS CBT CANO C.MX C.BA C BURL BOLT BNP.PA BLUE AZPN AYTU AXDX ALO.PA ADSK 0IM1.L 0IIB.L 0I4P.L WEBR VYNT VWE VVOS VAC URI TTWO TCBK SYRS SYK SMAWF SILK SIEN.MX SIEGY SIE.DE SIA.BR SCPL SANA RNO.PA RES RCKT RBLX PFE PEN OTRK OPY NVRO NUE MDT LULU KALA IPW GE FULC FANG EW EGP EBAY DXCM DBN.MX DBK.PR DBK.MI DBK.DE DB DADA CYRX CWGRP CVI CRSP CRCT COWNL COWN CMAX CF.TO CDXC CCORF BSX BOXL BLFS BFI BCY.DE BCSN.MX BCS.BA BCS BCLYF BBBY BAX BARC.L AUTO ALGT ALBO AGIO AEO

Read more →
Published at

Jan 27, 2022 10:30 PM

by globenewswire.com

mixed

mixed

Applied Molecular Transport Announces Board Appointments

John W. Smither Appointed to its Board of Directors and Named Audit Committee Chair Graham K. Cooper Named Executive Chair Helen S. Kim Named Lead...

AMTI UBX EFTR ARQT AMGN AKAOQ

Read more →
Published at

Oct 4, 2021 7:00 AM

by insidermonkey.com

mixed

mixed

Hedge Funds Are Piling Into Unity Biotechnology, Inc. (UBX)

Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).

UBX ODC ESXB CVEO 0YC0.L XGN VIAO CVCY CMTV BOCH

Read more →